📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Zyngenia

1.1 - Company Overview

Zyngenia Logo

Zyngenia

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biotherapeutics focused on the development of next-generation antibody-derived drugs.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Zyngenia

Theraclion Logo

Theraclion

HQ: France Website
  • Description: Provider of high-intensity focused ultrasound (HIFU) echotherapy medical equipment, combining HIFU with standard ultrasound for non-invasive treatment and target localization. Solutions include SONOVEIN for varicose veins; ECHOPULSE for thyroid nodules and breast fibroadenoma; CURE-OP for combinational cancer therapy integrating ultrasound with radiotherapy; and EPack single-use disposables for cooling and coupling.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Theraclion company profile →
Mevion Medical Systems Logo

Mevion Medical Systems

HQ: United States Website
  • Description: Provider of innovative, safe, and effective radiation therapy solutions for the treatment of cancer, pioneering modern proton therapy systems and transforming advances in medical technology and science into practical clinical solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mevion Medical Systems company profile →
Armune Bioscience Logo

Armune Bioscience

HQ: United States Website
  • Description: Provider of molecular diagnostic and prognostic tests for prostate, lung and breast cancers, enabling physicians and patients to make more personalized treatment decisions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Armune Bioscience company profile →
Gloucester Pharma Logo

Gloucester Pharma

HQ: United States Website
  • Description: Provider of biopharmaceutical development, acquiring clinical-stage oncology drug candidates and advancing them through regulatory approval and commercialization; owned by Celgene. Its first compound, romidepsin, is a late-stage oncology drug candidate.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Gloucester Pharma company profile →
CASI Pharmaceuticals Logo

CASI Pharmaceuticals

HQ: United States Website
  • Description: Provider of business development aimed at building a pipeline through mutually beneficial transactions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CASI Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Zyngenia

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Zyngenia

2.2 - Growth funds investing in similar companies to Zyngenia

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Zyngenia

4.2 - Public trading comparable groups for Zyngenia

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Zyngenia

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Zyngenia

What does Zyngenia do?

Zyngenia is a provider of biotherapeutics focused on the development of next-generation antibody-derived drugs.

Who are Zyngenia's competitors?

Zyngenia's competitors and similar companies include Theraclion, Mevion Medical Systems, Armune Bioscience, Gloucester Pharma, and CASI Pharmaceuticals.

Where is Zyngenia headquartered?

Zyngenia is headquartered in United States.

How many employees does Zyngenia have?

Zyngenia has 1,000 employees 🔒.

When was Zyngenia founded?

Zyngenia was founded in 2010 🔒.

What sector and industry vertical is Zyngenia in?

Zyngenia is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Zyngenia

Who are the top strategic acquirers in Zyngenia's sector and industry

Top strategic M&A buyers and acquirers in Zyngenia's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Zyngenia?

Top strategic M&A buyers groups and sectors for Zyngenia include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Zyngenia's sector and industry vertical

Which are the top PE firms investing in Zyngenia's sector and industry vertical?

Top PE firms investing in Zyngenia's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Zyngenia's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Zyngenia's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Zyngenia's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Zyngenia include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Zyngenia's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Zyngenia?

The key public trading comparables and valuation benchmarks for Zyngenia include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Zyngenia for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Zyngenia with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Zyngenia's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Zyngenia with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Zyngenia's' sector and industry vertical?

Access recent funding rounds and capital raises in Zyngenia's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Zyngenia